Abstract
Introduction: The diagnosis of long segment Hirschsprung's disease (LSHD) is frequently delayed.
Our purpose was to: 1) summarize contrast enema (CE) findings in patients with LSHD,
and 2) evaluate the utility of CE by comparing LSHD patients managed with/without
pre-biopsy CE.
Methods: All LSHD cases (transition zone [TZ] proximal to the splenic flexure) treated between
1984 and 2009 were stratified according to whether a pre-biopsy CE was done (Group
1) or not (Group 2). CE were reviewed by a single pediatric radiologist, and the original
reports were categorized as “helpful”, “inconclusive” or “misleading”. Group comparisons
included elapsed days from admission to diagnostic rectal biopsy/first operation and
initial hospitalization length of stay (LOS).
Results: 29 patients (16 in Group 1; 13 in Group 2) were identified. CE review revealed TZ
in 7/16 (44%); and of these, 6 (86%) underestimated the actual aganglionic segment
length. 6/16 (38%) original CE reports were “misleading”. Overall, Group 1 patients
experienced a significant delay in time to biopsy (p=0.047), first operation (p=0.005),
and showed a trend towards prolonged LOS.
Conclusions: Pre-biopsy CE offers little to the diagnosis of LSHD and may contribute to diagnosis/treatment
delays. Even if a TZ is recognized in biopsy proven HD, the predicted aganglionic
segment length should not guide the operative planning.
Key words
long segment Hirschsprung's disease - contrast enema - diagnosis - outcome
References
- 1
Haricharan RN, Georgeson KE.
Hirschsprung disease.
Semin Pediatr Surg.
2008;
17
266-275
- 2
Martucciello G.
Hirschsprung's disease, one of the most difficult diagnoses in pediatric surgery:
a review of the problems from clinical practice to the bench.
Eur J Pediatr Surg.
2008;
18
140-149
- 3
O’Donovan AN, Habra G, Somers S. et al .
Diagnosis of Hirschsprung's disease.
AJR Am J Roentgenol.
1996;
167
517-520
- 4
Diamond IR, Casadiego G, Traubici J. et al .
The contrast enema for Hirschsprung disease: predictors of a false-positive result.
J Pediatr Surg.
2007;
42
792-795
- 5
Jamieson DH, Dundas SE, Belushi SA. et al .
Does the transition zone reliably delineate aganglionic bowel in Hirschsprung's disease?.
Pediatr Radiol.
2004;
34
811-815
- 6
de Lorijn F, Kremer LC, Reitsma JB. et al .
Diagnostic tests in Hirschsprung disease: a systematic review.
J Pediatr Gastroenterol Nutr.
2006;
42
496-505
- 7
Proctor ML, Traubici J, Langer JC. et al .
Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's
disease: Implications for surgical approach.
J Pediatr Surg.
2003;
38
775-778
- 8
Langer JC, Durrant AC, de la Torre L. et al .
One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience
with 141 children.
Ann Surg.
2003;
238
569-583
discussion 583–585
- 9
Somme S, Langer JC.
Primary versus staged pull-through for the treatment of Hirschsprung disease.
Semin Pediatr Surg.
2004;
13
249-255
- 10
Dasgupta R, Langer JC.
Hirschsprung disease.
Curr Probl Surg.
2004;
41
942-988
- 11
Moore SW.
Total colonic aganglionosis and Hirschsprung's disease: shades of the same or different?.
Pediatr Surg Int.
2009;
25
659-666
- 12
De Campo JF, Mayne V, Boldt DW, De Campo M.
Radiological findings in total aganglionosis coli.
Pediatr Radiol.
1984;
14
205-209
- 13
Stranzinger E, DiPietro MA, Teitelbaum DH, Strouse PJ.
Imaging of total colonic Hirschsprung disease.
Pediatr Radiol.
2008;
38
1162-1170
Correspondence
Dr. Erik D. Skarsgard
University of British Columbia
Pediatric General Surgery
K0-123 ACB
V6H 3V4 Vancouver
Canada
Telefon: +001 604 875 3744
Fax: +001 604 875 2721
eMail: eskarsgard@cw.bc.ca